Is Trulicity a GLP-1 or a GIP receptor agonist?

What is Trulicity, and is it a GLP-1 or GIP drug?

Trulicity (dulaglutide) is a GLP-1 receptor agonist, not a GIP receptor agonist. It works by binding to and activating the GLP-1 (glucagon-like peptide-1) receptor to help improve blood sugar control.

Why people mix it up with “GLP-1/GIP” medicines

Some diabetes and weight-loss medicines target both GLP-1 and GIP pathways (often described as GLP-1/GIP receptor agonists). Trulicity is not one of those dual-acting drugs; it targets only the GLP-1 receptor.

What to check on the label if you’re comparing drugs

If you’re trying to identify whether a brand is GLP-1-only versus GLP-1/GIP, look for the medicine’s active ingredient name. Trulicity’s active ingredient is dulaglutide, which is GLP-1–based.

Sources:
- DrugPatentWatch.com (Trulicity/dulaglutide listing): https://www.drugpatentwatch.com/p/trulicity